Area of research
Genetics · Pathology and Forensic Medicine
Research interest
Research interests include Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Immunodeficiency and Autoimmune Disorders, and Chronic Myeloid Leukemia Treatments.
Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis
Dose reductions in patients with Waldenström macroglobulinaemia treated with ibrutinib
Predictors of hematologic response and survival with stem cell transplantation in <scp>AL</scp> amyloidosis: A 25‐year longitudinal study
Light chain amyloidosis associated with Waldenström macroglobulinemia: treatment and survival outcomes
Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia
Diagnostic Next-generation Sequencing Frequently Fails to Detect MYD88L265P in Waldenström Macroglobulinemia
Bone marrow involvement and subclonal diversity impairs detection of mutated <i>CXCR4</i> by diagnostic next‐generation sequencing in Waldenström macroglobulinaemia
Predictive factors of outcomes in patients with <scp>AL</scp> amyloidosis treated with daratumumab
Natural history of Waldenström macroglobulinemia following acquired resistance to ibrutinib monotherapy
Immunopathology of Hyperinflammation in COVID-19
<i>CXCR4</i> mutation subtypes impact response and survival outcomes in patients with Waldenström macroglobulinaemia treated with ibrutinib
CXCR4 S338X clonality is an important determinant of ibrutinib outcomes in patients with Waldenström macroglobulinemia
Acquired mutations associated with ibrutinib resistance in Waldenström macroglobulinemia
Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214)